Epsilon M&A Deal Report - Clinique Développement
Transaction Multiples for the Valuation of Private Companies
Le Noble Age (LNA Santé) / Clinique Développement
No EMAT :
100887
Announced Date :
18/06/2020
Type :
Exit ,Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Le Noble Age (LNA Santé)
Target :
Clinique Développement
Country :
Seine-Maritime
Sector of activity :
- Health Care Providers > Health Care Providers, Medical Equipment and Supplies > Health, Pharmaceuticals & Biotechnology > Clinics and hospitals
Business Description :
Founded by Dr. Tanguy de la Bourdonnaye in 1997, Clinique Développement owns and operates medical and surgical centers . > Provides healthcare services in the areas of digestive and visceral...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
|
|
|
|
|
|
| Current |
Rating :
*
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Clinics and hospitals » = 118
| Date | Acquirer | Target | Country | Multiples | See details |
| 12/02/2019 | Private Group Led by Signet Healthcare Partners & RoundTable Healthcare Partners | OTC-Business of Moberg Pharma (MPJ OTC) | Sweden | *** | 100875 |
| 30/11/2019 | Private Group led by Omnes Capital | Biofutur | Val-D'Oise | * | 100831 |
Source: Epsilon Research / EMAT
